Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means

Abbott, 1996, Transporting therapeutics across the blood-brain barrier, Mol Med Today, 2, 106, 10.1016/1357-4310(96)88720-X

Barth, 1997, Boron neutron capture therapy of brain tumors: Enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption, Cancer Res, 57, 1129

Berk, 1995, Protein kinases as mediators of fluid shear stress stimulated signal transduction in endothelial cells: A hypothesis for calcium-dependent and calcium-independent events activated by flow, J Biomech, 28, 1439, 10.1016/0021-9290(95)00092-5

Blasberg, 1990, A review of hyperosmotic blood-brain barrier disruption in seven experimental brain tumor models, Pathophysiology of the Blood-Brain Barrier, 197

Bobo, 1994, Convection-enhanced delivery of macromolecules in the brain, Proc Natl Acad Sci U S A, 91, 2076, 10.1073/pnas.91.6.2076

Brem, 1995, The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation in the treatment of newly diagnosed malignant gliomas: Phase I trial, J Neurooncol, 26, 111, 10.1007/BF01060217

Brem, 1995, Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas, Lancet, 345, 1008, 10.1016/S0140-6736(95)90755-6

Brightman, 1965, The distribution within the brain of ferritin injected into cerebrospinal fluid compartments, J Cell Biol, 26, 99, 10.1083/jcb.26.1.99

Brightman, 1973, Osmotic opening of tight junctions in cerebral endothelium, J Comp Neurol, 152, 317, 10.1002/cne.901520402

Brodie, 1960, The importance of dissociation constant and lipid-solubility in influencing the passage of drugs into the cerebrospinal fluid, J Pharmacol Exp Ther, 130, 20

Broman, 1949, Experimental study of contrast media for cerebral angiography with reference to possible injurious effects on the cerebral blood vessels, Acta Radiol, 31, 321, 10.3109/00016924909134716

Capala, 1996, Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy for brain tumors, Bioconjug Chem, 7, 7, 10.1021/bc950077q

Crossen, 1994, Neurobehavioral sequelae of cranial irradiation in adults: A review of radiation induced encephalopathy, J Clin Oncol, 12, 627, 10.1200/JCO.1994.12.3.627

Dahlborg, 1996, Non-AIDS primary CNS lymphoma: The first example of durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy, Cancer J Sci Am, 2, 166

Dahlborg, The potential for complete and durable response in non-glial primary brain tumors in pediatric patients and young adults with enhanced chemotherapy delivery, Cancer J Sci Am

Dascalu, 1995, Hyperosmotic modulation of the cytosolic calcium concentration in a rat osteoplast-like cell line, J Physiol (Lond), 486, 97, 10.1113/jphysiol.1995.sp020793

Davson, 1978, The environment of the neurone, Trends Neurosci, 1, 39, 10.1016/0166-2236(78)90016-4

Doran, 1995, Gene expression from recombinant viral vectors in the CNS following blood-brain barrier disruption, Neurosurgery, 36, 965, 10.1227/00006123-199505000-00012

Ehrlich, 1906, Uber die Beziehungen von chemische Constitution, Vertheilung, und Pharmakologischer Wirkung: Collected Studies in Immunity, 567

Finlay, 1996, Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors, J Clin Oncol, 14, 2495, 10.1200/JCO.1996.14.9.2495

Gancher, 1995, Dose and duration-dependent tolerance to rotational effects of apomorphine in a rat model of parkinsonism, J Pharmacol Exp Ther, 272, 275

Goldmann, 1909, Die äussere und innere sekretion des genden und gekranken Organismus im Licht der vitalen Färbung, Beitr Klin Chir, 64, 192

Goldmann, 1913, Vitalfärbung am Zentralnervensystem, Abh Preuss Akad Wiss Phys-Math, 1, 1

Hall, 1996, Antisense oligonucleotides for central nervous system tumors, Neurosurgery, 38, 376, 10.1097/00006123-199602000-00029

Heideman, 1995, Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors, J Clin Oncol, 13, 2247, 10.1200/JCO.1995.13.9.2247

Huwyler, 1996, Brain drug delivery of small molecules using immunoliposomes, Proc Natl Acad Sci U S A, 93, 14164, 10.1073/pnas.93.24.14164

Inamura, 1994, Bradykinin selectively opens blood-tumor barrier in experimental brain tumors, J Cereb Blood Flow Metab, 14, 862, 10.1038/jcbfm.1994.108

Inamura, 1994, Intracarotid infusion of RMP-7, a bradykinin analog: A method for selective drug delivery to brain tumors, J Neurosurg, 81, 752, 10.3171/jns.1994.81.5.0752

Karnovsky, 1967, The ultrastructural basis of capillary permeability studied with peroxidase as a tracer, J Cell Biol, 35, 213, 10.1083/jcb.35.1.213

Kerr, 1995, Regressions and cures of melanoma xenografts following treatment with monoclonal antibodyβ-lactamase conjugates in combination with anticancer prodrugs, Cancer Res, 55, 3558

Kroll, 1994, Differential permeability of the blood-tumor barrier in intracerebral tumor-bearing rats: Anti-drug antibody to achieve systemic drug rescue, Therap Immunol, 1, 333

Kroll, 1996, Increasing volume of distribution to brain with interstitial infusion: Dose, rather than convection, may be the most important factors, Neurosurgery, 38, 746, 10.1227/00006123-199604000-00024

Laske, 1994, Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice, J Neurosurg, 80, 520, 10.3171/jns.1994.80.3.0520

Lieberman, 1995, Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion, J Neurosurg, 82, 1021, 10.3171/jns.1995.82.6.1021

Markowsky, 1991, Methotrexate disposition following disruption of the blood-brain barrier, Ther Drug Monit, 13, 24, 10.1097/00007691-199101000-00002

Matsukado, 1996, Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7, Neurosurgery, 39, 125, 10.1097/00006123-199607000-00025

Miller, 1994, Pathology with clinical correlations of primary nervous system non-Hodgkin's lymphoma: The Massachusetts General Hospital experience 1958-1989, Cancer, 74, 1383, 10.1002/1097-0142(19940815)74:4<1383::AID-CNCR2820740432>3.0.CO;2-1

Modjtahedi, 1991, The receptor for EGF and its ligands: Expression, prognostic value and target for therapy in cancer, Int J Oncol, 4, 227

Muldoon, 1995, Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus and iron oxide particles to normal rat brain, Am J Pathol, 147, 1840

Muldoon, 1998, Demonstration of a physiologic barrier distal to the anatomic blood-brain barrier. Proceedings of the American Association for Cancer Research

Muldoon, 1994, Characterization of the molecular defect in a feline model for Type II GM2 gangliosidosis (Sandhoff disease), Am J Pathol, 144, 1109

Nakano, 1996, Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide, Cancer Res, 56, 4027

Nazzaro, 1991, A new model of systemic drug rescue based on permeability characteristics of the blood-brain barrier in intracerebral abscess-bearing rats, J Neurosurg, 74, 467, 10.3171/jns.1991.74.3.0467

Neuwelt, 1989, Implications of the Blood-Brain Barrier and Its Manipulation

Neuwelt, 1994, Osmotic blood-brain barrier modification: Increasing delivery of diagnostic and therapeutic agents to the brain, Providing Pharmacological Access to the Brain: Methods in Neuroscience, 52, 10.1016/B978-0-12-185291-7.50010-2

Neuwelt, 1988, Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruption, Cancer Res, 48, 4725

Neuwelt, 1996, In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity, Cancer Res, 56, 706

Neuwelt, 1980, Effect of osmotic blood-brain barrier disruption on methotrexate pharmacokinetics in the dog, Neurosurgery, 7, 36, 10.1227/00006123-198007000-00006

Neuwelt, 1985, Characterization of a new model of GM2 gangliosidosis (Sandhoff's disease) in Korat cats, J Clin Invest, 76, 482, 10.1172/JCI111997

Neuwelt, 1995, Gene replacement therapy in the central nervous system: Viral vector-mediated therapy of global neurodegenerative disease, Behav Brain Sci, 18, 1, 10.1017/S0140525X00037237

Neuwelt, 1987, Increased delivery of tumor-specific monoclonal antibodies to brain after osmotic blood-brain barrier modification in patients with melanoma metastatic to the central nervous system, Neurosurgery, 20, 885, 10.1227/00006123-198706000-00011

Neuwelt, 1994, Delivery of virussized iron oxide particles to rodent CNS neurons, Neurosurgery, 34, 777

Neuwelt, 1994, Therapeutic dilemma of disseminated CNS germinoma and the potential of increased platinum-based chemotherapy delivery with osmotic blood-brain barrier disruption, Pediatr Neurosurg, 21, 16, 10.1159/000120809

Nilaver, 1995, Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors following osmotic blood-brain barrier disruption, Proc Natl Acad Sci U S A, 92, 9829, 10.1073/pnas.92.21.9829

Nomura, 1994, Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors, Brain Res, 659, 62, 10.1016/0006-8993(94)90863-X

Oldfield, 1993, Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir, Hum Gene Ther, 4, 39, 10.1089/hum.1993.4.1-39

Prokai-Tatrai, 1996, Brain-targeted delivery of a leucine-enkephalin analogue by retrometabolic design, J Med Chem, 39, 4775, 10.1021/jm960356e

Ram Z , CulverKW, OshiroEM, ViolaJJ, DeVroomHL, OttoE, LongZ, ChiangY, McGarrityGJ, MuulLM, KatzD, BlaeseRM, OldfieldEH Summary of results and conclusions of the gene therapy of malignant brain tumors clinical study. Proceedings of the AANS, Denver, April 22-27, 1995.

Rapoport, 1970, Effect of concentrated solutions on blood-brain barrier, Am J Physiol, 219, 270, 10.1152/ajplegacy.1970.219.1.270

Rapoport, 1976, Blood-Brain Barrier in Physiology and Medicine

Rapoport, 1986, Tight-junctional modification as the basis of osmotic opening of the blood-brain barrier, Ann N Y Acad Sci, 481, 250, 10.1111/j.1749-6632.1986.tb27155.x

Rapoport, 1972, Testing of a hypothesis of osmotic opening of the blood-brain barrier, Am J Physiol, 223, 323, 10.1152/ajplegacy.1972.223.2.323

Reese, 1967, Fine structural localization of a blood-brain barrier to exogenous peroxidase, J Cell Biol, 34, 208, 10.1083/jcb.34.1.207

Remsen, 1996, MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: The potential for noninvasive diagnosis, AJNR Am J Neuroradiol, 17, 411

Remsen, 1997, Long-term toxicity and neuropathology associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery, Neurosurgery, 40, 1034, 10.1097/00006123-199705000-00030

Remsen, 1995, Decreased delivery and acute toxicity of cranial irradiation and chemotherapy given with osmotic blood-brain barrier disruption in a rodent model: The issue of sequence, Clin Cancer Res, 1, 731

Robinson, 1991, Model For drug uptake by brain tumors: Effects of osmotic treatment and of diffusion in brain, J Cereb Blood Flow Metab, 11, 165

Roman-Goldstein, 1991, Effects of gadopentetate dimeglumine administration after osmotic blood-brain barrier disruption: Toxicity and MR imaging findings, AJNR Am J Neuroradiol, 12, 885

Roman-Goldstein, 1994, Effects of Gd-DTPA after osmotic BBB disruption in a rodent model: Toxicity and MR findings, J Comput Assist Tomogr, 18, 731, 10.1097/00004728-199409000-00010

Roman-Goldstein, 1994, Osmotic blood-brain barrier disruption: CT and radionuclide imaging, AJNR Am J Neuroradiol, 15, 581

Stern, 1921, Rapports entre le liquide céphalo-rachidien et la circulation sanquine, Arch Int Physiol, 17, 138

Stern, 1922, Les rapports entre le liquide céphalorachidien et les éléments nerveux de l'axe cérébrospinal, Arch Int Physiol, 17, 391

Trail, 1993, Cure of xenografted human carcinomas by BR96-doxorubicin immuno-conjugates, Science, 261, 212, 10.1126/science.8327892

Walter, 1995, Intratumoral chemotherapy, Neurosurgery, 37, 1129, 10.1227/00006123-199512000-00013

Wang, 1996, Filamen translocation is an early endothelial cell inflammatory response to bradykinin: Regulation by calcium, protein kinases, and protein phosphatases, J Cell Biochem, 62, 383, 10.1002/(SICI)1097-4644(199609)62:3<383::AID-JCB8>3.0.CO;2-N

Williams, 1995, Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain barrier in the treatment of intracranial neoplasms, Neurosurgery, 37, 17, 10.1227/00006123-199507000-00003

Yang, 1996, Enhanced delivery of boronophenylalanine by means of intracarotid injection and blood-brain barrier disruption for neutron capture therapy, Neurosurgery, 38, 985, 10.1097/00006123-199605000-00027

Zünkeler, 1996, Quantification and pharmacokinetics of blood-brain barrier disruption in humans, J Neurosurg, 85, 1056, 10.3171/jns.1996.85.6.1056

Zünkeler, 1996, Hyperosmolar blood-brain barrier disruption in baboons: An in vivo study using positron emission tomography and rubidium-82, J Neurosurg, 84, 494, 10.3171/jns.1996.84.3.0494